Related Experiment Video
Updated: Jul 5, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Contribution of inflammation to vascular disease in chronic kidney disease patients
Insights
Chronic kidney disease (CKD) involves high mortality, often from cardiovascular disease (CVD). Inflammation in CKD patients, common in developing nations, exacerbates both CKD progression and CVD risk.
Area of Science:
- Nephrology
- Cardiology
- Immunology
Background:
- Chronic kidney disease (CKD) is linked to high mortality, primarily due to cardiovascular disease (CVD).
- Chronic low-grade inflammation, indicated by elevated pro-inflammatory cytokines and C-reactive protein (CRP), is a hallmark of CKD.
- This inflammation may drive atherosclerotic CVD and contribute to CKD progression, creating a detrimental cycle.
Discussion:
- Inflammation in CKD is multifactorial, influenced by comorbidities and the declining renal function.
- Pro-inflammatory cytokines are implicated in the development of metabolic syndrome.
- Developing countries face a data gap regarding inflammation, protein-energy wasting (PEW), and CVD in CKD patients.
Key Insights:
- Lifestyle changes, 'westernized' diets, and prevalent chronic infections in developing countries may increase inflammation, PEW, and CVD risk in CKD patients.
- Genetic variations can influence inflammatory responses, nutritional status, and CVD susceptibility across different populations.
- Understanding these factors is crucial for managing CKD and its complications.
Outlook:
- Further epidemiological studies are needed, especially in developing countries, to fully grasp the prevalence and impact of inflammation on CKD, PEW, and CVD.
- Targeting inflammation could be a key strategy in mitigating cardiovascular risks and slowing disease progression in CKD.
- Addressing nutritional and lifestyle factors, alongside managing infections, may help reduce the inflammatory burden in CKD patients globally.
Abstract:
Chronic kidney disease (CKD) is characterized by an exceptionally high mortality rate, much of which results from cardiovascular disease (CVD). Chronic low-grade inflammation, as evidenced by increased levels of pro-inflammatory cytokines and C-reactive protein (CRP), is a common feature of CKD and may cause atherosclerotic CVD through various pathogenetic mechanisms. Evidence suggests that persistent inflammation may also be a risk factor for progression of CKD, which may result in a vicious inflammation-driven circle. The causes of inflammation in CKD are multifactorial. The influence of various comorbidities may contribute to inflammation in the setting of progressive loss of renal function. Available data suggest that pro-inflammatory cytokines also play a central role in the genesis of the metabolic syndrome. There is a lack of epidemiological data on the prevalence and consequences of inflammation in relation to protein-energy wasting (PEW) and CVD in CKD patients from developing countries. The 'westernization' of nutritional intakes and changes of life style besides the high prevalence of chronic infections in developing countries are possible additive contributors to a high prevalence of inflammation, PEW and CVD among CKD patients. Also, genetic differences may affect inflammatory responses and nutritional status and, thus, the susceptibility to CVD in different regions.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Inflammation: Introduction
Acute Kidney Injury II: Pathophysiology
Chronic Kidney Disease III: Interprofessional Care
Inflammatory Response I: Vascular and Cellular